RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
  • Executives of Company Accused of Pulling Wool Over Eyes of EU Regulators Sentenced to Prison

    • 10 December 2013
    The former CEO of a now-disgraced manufacturer of breast implants that was accused of willfully misleading regulatory officials for years has been found guilty by a French court and sentenced to four years in Jail. Background Jean-Claude Mas, former CEO of the now-defunct manufacturer Poly Implant Prothese (PIP), was accused in 2010 of distributing hundreds of thousands of breast implant products made with deficient, industrial-grade silicone without the approval of reg...
  • False Statements on Facebook Regarding FDA-Regulated Product Lead to Jail Time for Iowa Man

    Rarely does one person influence how the US Food and Drug Administration (FDA) looks at a company, but every so often one person comes along and-for better or worse-changes the agency's perspective. This article is about the latter of those two possibilities. Background An example of the former may well be Dinesh Thakur, who blew the whistle on deficient practices at Ranbaxy, practices for which the company has now paid hundreds of millions of dollars. But if that's ...
  • House Passes Bill Enhancing Penalties for Counterfeiters

    • 19 June 2012
    The US House of Representatives passed a bill on Monday, 18 June that would update the US' criminal code to establish harsher penalties for those found guilty of counterfeiting pharmaceutical products. The legislation, the Counterfeit Drug Penalty Enhancement Act of 2011 , is sponsored by Rep. Patrick Meehan (R-PA) and was introduced in the House in December 2011. An identically-titled companion bill first sponsored by Sen. Patrick Leahy (I-VT) is still before the S...